Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Lightning Might Not Strike Twice for Carnival

By Josh Enomoto, InvestorPlace Contributor
Although CCL stock has been a surprising winner so far this year, that’s likely about to change due to shifting circumstances.

Lucid Stock Has Several Positive Signs, But Lay off Until After Earnings

By Alex Sirois, InvestorPlace Contributor
LCID stock hasn't had a great start to 2022 but the real test comes with earnings that drop on feb. 28 and production in 2022.

Has Alphabet Just Opened the Stock Split Floodgates?

By Will Ashworth, InvestorPlace Contributor
Alphabet just announced a 20-for-1 stock split. There’s no question more companies are going to do them. Is GOOG stock setting a trend?      

Opendoor Stock Is Cheap, But Don’t Buy It Until It Hits Rock Bottom

By Thomas Niel, InvestorPlace Contributor
Although down to its SPAC offering price, OPEN stock could still continue to drop, as the housing market cools down. Hold off on it for now.

UiPath Needs a Better Market to Really Shine

By Dana Blankenhorn, InvestorPlace Contributor
UIPath represents a great growth stock opportunity in a market that doesn't want a growth stock opportunity. PATH stock is one to watch.

Sundial Growers Inadvertently Gave Investors a Lesson on Cryptos

By Josh Enomoto, InvestorPlace Contributor
All the effort that Sundial Growers expended to keep SNDL stock listed on the Nasdaq reveals a greater truth about cryptocurrencies.

Palantir’s Post-Earnings Drop Isn’t the End of Its Extended Selloff

By Thomas Niel, InvestorPlace Contributor
Even as Palantir's pivot towards more commercial sales may be working, valuation concerns could still push PLTR stock lower.

Avoid Palantir Technologies Stock, It Is Not for the Weak Hearted

By Vandita Jadeja
The fourth quarter results have been disappointing and PLTR stock may continue the downward spree. Avoid the stock.

fuboTV: Why Preliminary Results Should Make You Skeptical

By Stavros Georgiadis, CFA, InvestorPlace Contributor
FUBO stock has been weak in 2022. Upcoming Q4 2021 earnings will be a catalyst for a reversal or continuation of the selloff.

Opendoor Won’t Suffer From The Same Fate As Zillow

By Muslim Farooque, InvestorPlace Contributor
Opendoor's has a profitable iBuying business unlike Zillow and is leveraging it to move into other profitable verticals to boost OPEN stock

You’ve Got Nerves of Steel if You Buy FuboTV Stock Before Earnings

By Will Ashworth, InvestorPlace Contributor
Roku recently reported Q4 results that were less than expected. FUBO stock got hit. Down over 15% in the past week, should you buy shares? 

Novavax Stock’s Wild Moves Leave Little Room for Error

By Nicolas Chahine, InvestorPlace Contributor
NVAX stock can still bring profits for traders and investors as long as they are willing to accept the risks that it brings.

AMC Entertainment’s Upcoming Q4 Earnings Should Showcase Its Turnaround

By Mark R. Hake, CFA
AMC pre-released good revenue and adj. EBITDA numbers and refinanced high-cost debt, raising the value of AMC stock by at least one-third to $24.00.

There’s No Need to Stretch for Profit With Coupang Stock

By Dana Blankenhorn, InvestorPlace Contributor
CPNG stock makes its money by building delivery infrastructure in South Korea for online shopping, much like Amazon has in the U.S.

What Matterport Does and Why it Matters

By Josh Enomoto, InvestorPlace Contributor
Although MTTR stock appears to be a compelling investment, Matterport is doing poorly. Here’s why that might be and why it matters.

Is Moderna the Next Gilead or the Next Regeneron?

By Dana Blankenhorn, InvestorPlace Contributor
MRNA stock is seen purely as a Covid-19 play. Until Moderna can prove it's not a one-hit wonder, shares are likely to remain depressed.

Post-SPAC Black Rifle Coffee Stock Needs Some Time to Percolate

By Alex Sirois, InvestorPlace Contributor
Black Rifle Coffee Company's strong fanbase likes both the company's purpose and product, though, admittedly, BRCC stock may not be everyone's cup of tea.

If it Can Deliver, Fisker is Worthy of a Speculative Wager

By Josh Enomoto, InvestorPlace Contributor
If Fisker can deliver on the promises laid forth in its website, speculators will want to pay close attention to FSR stock.

Traders Starting to Buy Into Sundial’s Comeback Story

By Ian Bezek, InvestorPlace Contributor
Investors may finally be done punishing SNDL stock as the company looks to transform itself into a diversified cannabis platform.
Load More Articles